SKAMEX SPOTKA AKCYJNA tenders – contracts won
Public contracts won and contractor statistics
- Lots won
- 1
- Win rate
- 25%
- Value won
- 69 666 zł
- Buyers
- 1
Most often wins with
Value won and average competition available in Mimira Market Analysis.
| Buyer | Lots won | Value won | Avg. competition | Win rate |
|---|---|---|---|---|
 | 1 |
Recent tenders won by SKAMEX SPOTKA AKCYJNA
| Tender subject | Buyer | Value | Award date |
|---|---|---|---|
| A.2025 Dostawa wyrobów medycznychŚląskie | Uniwersyteckie Centrum Kliniczne Im. Prof. K. Gibińskiego Śląskiego Uniwersytetu Medycznego W Katowicach | — | |
See the full Market Analysis data Full award history, bid values, competition and contractor performance – in Mimira Market Analysis. | |||
Frequently asked questions
Public procurement summary for SKAMEX SPOTKA AKCYJNA
How many tenders has SKAMEX SPOTKA AKCYJNA won?
SKAMEX SPOTKA AKCYJNA has won 1 contract lots in public procurement worth an estimated 69 666 zł in total. The company's bids were chosen by 1 different buyers, with a win rate of 25% across the tenders it took part in.
What is the largest contract won by SKAMEX SPOTKA AKCYJNA?
The highest value among SKAMEX SPOTKA AKCYJNA's recently awarded contracts is 69 666 zł – a contract awarded by Uniwersyteckie Centrum Kliniczne Im. Prof. K. Gibińskiego Śląskiego Uniwersytetu Medycznego W Katowicach.
Which buyers does SKAMEX SPOTKA AKCYJNA work with most often?
The institutions that most often choose SKAMEX SPOTKA AKCYJNA's bids include Uniwersyteckie Centrum Kliniczne Im. Prof. K. Gibińskiego Śląskiego Uniwersytetu Medycznego W Katowicach. See their profiles to check who else competes for these contracts.
In which regions does SKAMEX SPOTKA AKCYJNA win tenders?
Most of SKAMEX SPOTKA AKCYJNA's recent awards are in the province of Śląskie.
Where to find data on tenders won by SKAMEX SPOTKA AKCYJNA?
The data comes from contract award notices published in BZP and TED. The full award history, bid values and competition analysis for SKAMEX SPOTKA AKCYJNA are available in Mimira Market Analysis.